Yonkenafil is a phosphodiesterase type 5 inhibitor primarily developed for the treatment of erectile dysfunction by promoting smooth muscle relaxation. This category provides access to high-quality reference… Read more






Yonkenafil is a phosphodiesterase type 5 inhibitor primarily developed for the treatment of erectile dysfunction by promoting smooth muscle relaxation. This category provides access to high-quality reference standards essential for the comprehensive analysis of the active pharmaceutical ingredient. Laboratories utilize these compounds, including specific synthetic impurities and related degradation products, to facilitate accurate impurity profiling and ensure stringent quality control during manufacturing. The inclusion of stable isotope labelled compounds, such as deuterated Yonkenafil, allows for precise quantification using mass spectrometry-based techniques. By incorporating these materials into analytical workflows, researchers can effectively perform method validation and meet regulatory requirements throughout the development lifecycle of the drug, ensuring both the purity and safety of the final pharmaceutical product.